News Release: July 22, 2025
Allylamine Price, Production, Latest News and Developments in 2025
Allylamine, a critical intermediate in the synthesis of pharmaceutical and agricultural chemicals, continues to attract attention due to its rising demand and evolving production landscape. This article provides a comprehensive overview of Allylamine price news, sales volume, production developments, and trade movements, offering the most recent updates for 2025.
Allylamine Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
Between 2019 and 2024, Allylamine prices have shown significant fluctuations due to a combination of raw material volatility, geopolitical tensions, industrial demand, and supply chain dynamics.
In 2019, the average Allylamine price stood at approximately $2,100/MT. Stable raw material availability and moderate demand growth kept the price within a narrow band. However, 2020 brought disruption due to the COVID-19 pandemic. The lockdowns impacted both production and global supply chains. Prices dipped briefly to $1,850/MT in Q2 2020, before recovering to $2,000/MT by the end of the year, driven by resumed industrial activity and restocking behavior.
In 2021, prices surged due to increased demand from the pharmaceutical industry, particularly for intermediate compounds used in anti-infective therapies. The Allylamine price climbed to around $2,300/MT in Q3, peaking at $2,450/MT in Q4. Another key factor was the shortage of propylene, a key precursor, which impacted overall Allylamine production. The Allylamine sales volume also rose by 8% that year.
2022 saw a more volatile pattern. Early in the year, prices hovered around $2,400/MT, but disruptions in Eastern Europe and a spike in energy costs caused production constraints. Prices escalated to $2,750/MT by mid-year before stabilizing at $2,600/MT by Q4. Increased downstream demand in Asia, especially China and India, contributed to the growing sales volumes.
2023 marked a turning point for Allylamine price trend. With production facilities ramping up in Southeast Asia and better raw material availability, the average price declined gradually to $2,350/MT by year-end. However, seasonal demand spikes in the agrochemical industry occasionally pushed short-term prices higher.
In 2024, the Allylamine market experienced relative stability. The average global price was about $2,400/MT, with slight variations across regions. Demand from the pharmaceutical sector remained strong, while increased exports to Latin America and Europe supported growth. The production capacity in Asia continued to expand, notably in China and South Korea, enhancing global supply resilience.
Factors that significantly influenced Allylamine price over the years included:
- Crude oil and propylene price volatility impacting feedstock cost
- Shifts in pharmaceutical manufacturing hubs
- Regulatory changes affecting environmental compliance costs
- Technological upgrades reducing production cost in emerging economies
- Global shipping cost fluctuations and port congestion issues
Allylamine Price Trend Quarterly Update in $/MT – 2025 (Estimated)
The estimated quarterly Allylamine prices for 2025 are as follows, based on observed price movements and projected supply-demand scenarios:
- Q1 2025: $2,430/MT
The year began with modest growth in demand from agrochemical producers. Strong inventory levels kept prices stable.
- Q2 2025: $2,470/MT
Seasonal demand increase and tighter feedstock supply contributed to a marginal price hike.
- Q3 2025: $2,500/MT
Enhanced global industrial activity and increased import demand from Europe due to a temporary domestic shortage resulted in a notable increase.
- Q4 2025: $2,460/MT
Demand tapered post-harvest season, while Asian production capacities met global needs effectively, leading to a slight decline.
This quarterly trend reflects the evolving dynamics of global Allylamine production and sales strategies in response to regional market shifts.
Global Allylamine Import-Export Business Overview (2025)
The global Allylamine trade has expanded substantially in recent years, fueled by its growing application in pharmaceuticals, water treatment, and agrochemicals. In 2025, the international business surrounding Allylamine has become more diverse, with new players entering the production ecosystem and existing ones expanding their export footprints.
Asia-Pacific (APAC) remains the largest Allylamine production and export region. China leads global Allylamine production, followed by India and South Korea. With large-scale chemical infrastructure and favorable government policies, these countries have continued to scale up output. China’s export volume increased by 12% in the first half of 2025 compared to the same period in 2024. South Korea has positioned itself as a major supplier of high-purity Allylamine for pharmaceutical applications.
India has expanded its export markets in Africa, the Middle East, and Southeast Asia. The country also reported a notable 10% increase in Allylamine sales volume, driven by new production facilities in Gujarat and Maharashtra.
Europe, while a net importer of Allylamine, has several downstream facilities relying on this raw material. The region faced supply tightness in Q2 2025 due to regulatory shutdowns in Germany and France. Consequently, import volumes from Asia rose by 18%, mostly sourced from China and South Korea. Eastern European nations like Poland have begun importing Allylamine in larger quantities to support expanding pharmaceutical manufacturing bases.
North America, particularly the United States, maintains a balanced profile. While some Allylamine is produced domestically, the U.S. also imports from Canada, China, and India. The first half of 2025 saw moderate imports due to increased internal production supported by shale-based propylene feedstock. Canada continues to be a net importer due to limited local manufacturing.
Latin America has emerged as a growing destination for Allylamine exporters. Brazil and Mexico are the primary importers, driven by growing pharmaceutical and agrochemical sectors. Imports to Brazil rose by nearly 14% in the first two quarters of 2025. Several Latin American countries are also investing in local blending and formulation units that use Allylamine as a core ingredient.
Middle East and Africa have modest but rising Allylamine demand. The UAE and Saudi Arabia are actively importing Allylamine for pharmaceutical manufacturing. Some African nations, particularly Egypt and South Africa, have signed import agreements with Indian and Chinese producers. Growth in these regions is expected to remain strong, supported by improving healthcare infrastructure and industrial development.
Import-export challenges and developments in 2025:
- Shipping and Logistics: Global logistics remain under pressure with rising freight rates and occasional port congestion. However, dedicated chemical cargo carriers have improved delivery timelines for Allylamine shipments.
- Trade Agreements: India’s bilateral chemical export agreements with the EU and ASEAN have reduced tariffs, making Allylamine exports more competitive.
- Environmental Regulations: Stricter REACH compliance in the EU has led to re-evaluation of suppliers, with a preference for cleaner, certified production units, benefiting manufacturers with green credentials.
- Quality Standards and Audits: Importing nations have heightened scrutiny on product quality and traceability. This has led to increased documentation and testing requirements, especially in Europe and North America.
- Shift in Procurement Trends: Buyers are increasingly seeking multi-source procurement strategies to reduce reliance on a single supplier, especially after pandemic-era supply chain lessons.
As of mid-2025, global Allylamine sales volume is up 6% compared to the same time in 2024. Asia continues to dominate exports, while the demand in Europe and Latin America is seeing the fastest growth rate. Production capacity additions and process improvements are helping stabilize the Allylamine price news landscape and ensuring more predictable supply chains.
To access the full report and request a sample, visit: https://datavagyanik.com/reports/allylamine-market-size-production-sales-average-product-price-market-share-import-vs-export/
Allylamine Production Trends by Geography (2025)
The global production landscape for Allylamine has evolved significantly over the last few years. In 2025, the production of Allylamine is concentrated in several key regions, each playing a vital role in meeting global demand. The industry’s growth is being driven by rising applications in the pharmaceutical, water treatment, and agrochemical sectors. The following is a geographic overview of current Allylamine production trends:
Asia-Pacific (APAC)
Asia-Pacific continues to dominate the global Allylamine production market, accounting for more than 50% of total global capacity. China, India, and South Korea are the primary contributors. China leads in terms of production volume, with several large-scale chemical plants operating in regions such as Jiangsu, Shandong, and Zhejiang. These facilities benefit from integrated infrastructure, access to raw materials like propylene, and government support for chemical manufacturing.
China’s strategic focus on chemical intermediates and active pharmaceutical ingredient (API) supply has further fueled Allylamine output. The country has not only increased domestic production but has also enhanced its export capabilities to cater to Europe, the US, and Southeast Asia.
India is emerging rapidly as a major Allylamine producer. The growth is driven by expanding pharmaceutical and agrochemical manufacturing. Indian companies have invested in backward integration to reduce dependency on imports. Facilities in Gujarat and Maharashtra are operating near full capacity, and new expansion projects are underway in the southern states. Environmental compliance is a growing focus in India, with companies adopting cleaner technologies to meet both local and global regulatory standards.
South Korea plays a niche but significant role in the production of high-purity Allylamine. The country caters to the premium pharmaceutical segment and exports to markets such as the US and EU. South Korean firms prioritize research-driven manufacturing, ensuring high quality and stringent product specifications.
North America
The United States remains a stable and self-sufficient producer of Allylamine, although its total share of global production is smaller compared to Asia. US production benefits from access to shale gas-based feedstock, especially propylene, which reduces input costs. Companies in the Midwest and Gulf Coast regions are active in Allylamine synthesis, focusing on domestic consumption as well as limited exports to Canada, Mexico, and South America.
Canada and Mexico have smaller production capacities, with Mexico showing signs of growth due to favorable trade agreements and industrial development. Canadian production is primarily targeted for internal consumption.
Europe
Europe’s production of Allylamine has declined marginally over the past few years due to stringent environmental policies and high energy costs. However, some countries, including Germany and the Netherlands, continue to produce Allylamine for pharmaceutical use. Regulatory frameworks under REACH and high safety standards have made it expensive to maintain large-scale production. As a result, several European companies rely on imports from Asia.
Eastern European countries, particularly Poland and Hungary, are exploring small-scale production to support local pharmaceutical industries. However, these projects are still in early development stages.
Middle East and Africa
The Middle East is gradually entering the Allylamine production space. Countries like Saudi Arabia and the UAE are investing in chemical industrial parks with the goal of diversifying away from oil. While current production is limited, pilot plants and joint ventures with Asian firms are beginning to shape the regional output.
Africa’s Allylamine production is negligible at present. However, with growing demand from the pharmaceutical and agrochemical sectors, countries like South Africa and Egypt are exploring opportunities for regional manufacturing partnerships.
Latin America
Brazil and Argentina are showing increasing interest in producing Allylamine domestically. Brazil, in particular, is investing in industrial chemical zones where Allylamine production is being planned. The main driver is the demand from agrochemical manufacturers. Currently, most of the regional demand is met through imports, but local production is projected to rise by 2026.
Overall, 2025 sees Asia-Pacific as the production powerhouse, North America maintaining stable levels, and other regions making strategic entry moves. As environmental and trade dynamics continue to evolve, companies are investing in cleaner technologies and regional diversification to ensure sustainable and secure supply.
Allylamine Market Segmentation
The Allylamine market can be segmented by:
- Application
- End-use industry
- Purity level
- Geography
- Distribution channel
1. By Application
- Pharmaceutical intermediates
- Water treatment chemicals
- Agrochemicals
- Rubber chemicals
- Polymers and coatings
- Others (such as gas treatment, adhesives)
2. By End-use Industry
- Pharmaceuticals
- Agriculture
- Chemicals
- Water treatment plants
- Polymer and plastic industry
3. By Purity Level
- Industrial grade
- Pharmaceutical grade
- High-purity laboratory grade
4. By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
5. By Distribution Channel
- Direct supply (manufacturer to end-user)
- Distributors and traders
- Online chemical platforms
Explanation of Leading Segments
The leading segment in the Allylamine market is pharmaceuticals. Allylamine is extensively used as an intermediate in synthesizing drugs such as terbinafine, an antifungal medication. The pharmaceutical industry’s growth, especially in emerging economies like India and Brazil, is significantly increasing the demand for high-purity Allylamine. Developed countries are also witnessing consistent demand due to the aging population and expansion in chronic disease treatments.
Water treatment is another rapidly expanding application. Allylamine compounds are used in water-soluble polymers for treating municipal and industrial water. With growing global awareness about water pollution and regulatory standards, the demand from this segment is expected to rise. This trend is especially strong in Asia and Latin America, where water infrastructure projects are accelerating.
Agrochemicals constitute the third key segment. Allylamine-based compounds are used in the production of herbicides and plant protection chemicals. As food security becomes a central concern in many parts of the world, especially in Asia and Africa, Allylamine demand from this sector is growing. New formulations are being developed that require Allylamine as a critical input.
Among end-use industries, the pharmaceutical industry holds the largest market share due to the sheer volume and value of Allylamine used. This is followed by the chemical industry, which utilizes Allylamine for producing downstream products such as polymers, adhesives, and coatings.
By purity level, pharmaceutical-grade Allylamine commands a premium in the market due to strict quality specifications. Manufacturers in South Korea, the US, and select EU countries specialize in this grade. Industrial grade is more common and widely used in agrochemicals and water treatment.
Geographically, Asia-Pacific dominates across all segments due to high production, lower costs, and expanding end-user industries. North America remains a significant consumer, especially in pharmaceutical and water treatment segments. Europe, while facing regulatory challenges, still maintains demand from pharmaceutical and specialty chemical companies.
Direct supply continues to be the preferred distribution channel for large-scale buyers like pharmaceutical companies. However, the role of chemical distributors is becoming more prominent in regions like Latin America and Africa, where local sourcing relationships are still developing.
The Allylamine market segmentation highlights the compound’s broad utility across vital industries. Pharmaceutical and water treatment segments are expected to remain the dominant applications, while regional growth will continue to be driven by Asia-Pacific and Latin America through 2025 and beyond.